Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis - Wikidata - awgldk - TriplyDB

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

http://www.wikidata.org/entity/Q28343549

about

Effects of atovaquone and diospyrin-based drugs on the cellular ATP of Pneumocystis carinii f. sp. carinii Antiparasitic agent atovaquone Atovaquone maintenance therapy prevents reactivation of toxoplasmic encephalitis in a murine model of reactivated toxoplasmosis.Effect of 3-bromopyruvate and atovaquone on infection during in vitro interaction of Toxoplasma gondii and LLC-MK2 cells.Significant reduction of brain cysts caused by Toxoplasma gondii after treatment with spiramycin coadministered with metronidazole in a mouse model of chronic toxoplasmosis.Evaluation of Current and Emerging Antimalarial Medicines for Inhibition of Toxoplasma gondii Growth in Vitro

P2860

Q28343926-BADBB80B-2CDA-4117-ADA6-4B63B3C044F4 Q34107885-2FE21915-601E-4EBF-883E-1F9478538FB0 Q37625142-F28E27FD-DC8A-46D7-9343-59495FDBCA59 Q38863836-F00ADAA7-0584-4E47-87D3-262588B2E786 Q41968777-A5B03C1A-11C6-4D6A-9F3F-CC1EA8A8F16D Q56344152-D31D4034-0D33-4AEA-8F65-0C4BBF7942AE

P2860

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

http://www.wikidata.org/entity/Q28343549

description

1999 nî lūn-bûn

@nan

1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

name

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@ast

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@en

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@nl

type

label

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@ast

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@en

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@nl

prefLabel

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@ast

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@en

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@nl

P1433

Q28343549-FF9F4A30-CC1C-4020-A3C4-0CD5590BDAE2

P1476

Q28343549-13BA5858-98F6-402B-B180-49B8E06C3B19

P2093

Q28343549-0A14C1F7-531D-4C77-A815-AB5AB7A3BFA8

Q28343549-17699408-D20F-4A71-9EEB-37971FBDAACD

Q28343549-4165A3C5-348F-491B-868C-AD42F1E11BDD

Q28343549-5AB62854-9BF8-4B66-849F-4F6E4A8910AB

Q28343549-EB564210-0900-4360-BE12-D6E8E66C72EA

P2860

Q28343549-17C0D18A-7326-457C-B2E0-E58CBD00A02C

Q28343549-1DB4DEF9-92E4-40BE-8E32-DAA6073C92AA

Q28343549-26BB048E-E37F-4F8D-BAF8-24434A97CFD3

Q28343549-2C2951FC-BCBD-4636-A461-AFE5A2E3E212

Q28343549-2FF45388-4A4D-4D2A-9C5F-D550CA405EA0

Q28343549-36233038-1C47-4E8B-942A-C24C17B376CA

Q28343549-36CE950F-D6DA-412B-97F8-36DA3B100229

Q28343549-4A5B0AF2-5DE5-4CBF-8FFF-67CF3A89D87A

Q28343549-54AAFE5F-D762-4432-9180-B469CCA63FB4

Q28343549-68A6C65A-7086-44A8-8A21-A63378CCA9EE

P304

Q28343549-687A9386-2BCF-44D8-AEE8-63F1A81C4F0C

P31

Q28343549-73A01C08-D769-467D-838A-AB6B87E6FDB1

P407

Q28343549-2DFB8E30-A7AA-48D7-9658-BCC87C73C5BF

P433

Q28343549-29519FBC-056D-4209-BE55-ECFFA73411BB

P478

Q28343549-61A71F62-4562-4085-85D0-9491FE9C5841

P577

Q28343549-5E8756E7-0682-48EA-9660-F04DDB5BA033

P698

Q28343549-90A0E8AD-FFDE-4B19-BB55-5067AB4A57B6

P921

Q28343549-AC907D0F-FE71-4242-B69C-D6287E15B2D8

P932

Q28343549-B2BD3A65-300E-4447-AFC0-B22206AEADAB

P1433

Antimicrobial Agents and Chemotherapy

P1476

Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis

@en

P2093

A Nikolić

http://www.w3.org/2001/XMLSchema#string

B Bobić

http://www.w3.org/2001/XMLSchema#string

F Robert-Gangneux

http://www.w3.org/2001/XMLSchema#string

O Djurković-Djaković

http://www.w3.org/2001/XMLSchema#string

T Nikolić

http://www.w3.org/2001/XMLSchema#string

P2860

Use of uracil DNA glycosylase to control carry-over contamination in polymerase chain reactions

In vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against the cyst form of Toxoplasma gondii

In vivo assessment of antimicrobial agents against Toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice

Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii

Rifabutin is active in murine models of toxoplasmosis

In vitro and in vivo effects of rifabutin alone or combined with atovaquone against Toxoplasma gondii

Assessment of therapy for toxoplasma encephalitis. The TE Study Group.

Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin

Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases.

Effect of clindamycin on acute and chronic toxoplasmosis in mice

P304

2240-4

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P577

1999-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10471572

http://www.w3.org/2001/XMLSchema#string

P921

P932

89454

http://www.w3.org/2001/XMLSchema#string